Immix Biopharma, Inc. - Common Stock (IMMX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
IMMX on Nasdaq
Price per share
$5.64
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,765,928
Total reported value
$5,781,309
% of total 13F portfolios
0%
Share change
+436,277
Value change
+$912,474
Number of holders
31
Price from insider filings
$5.64
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 31 institutional investors reported holding 2,765,928 shares of Immix Biopharma, Inc. - Common Stock (IMMX).

Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$51,259 $5.64 0
2025 Q3 2,765,928 $5,781,309 +$912,474 $2.09 31
2025 Q2 2,262,228 $4,682,595 -$1,044,152 $2.07 23
2025 Q1 2,918,442 $4,902,496 +$70,569 $1.68 22
2024 Q4 2,870,949 $6,315,600 -$1,857,745 $2.20 22
2024 Q3 4,094,667 $6,102,781 -$618,016 $1.49 25
2024 Q2 4,429,414 $8,774,511 -$597,024 $1.98 29
2024 Q1 5,090,000 $15,715,858 +$12,671,335 $3.07 34
2023 Q4 783,068 $5,326,329 +$2,756,459 $6.92 28
2023 Q3 405,051 $1,385,659 -$652,595 $3.42 16
2023 Q2 633,819 $1,705,059 +$653,633 $2.69 17
2023 Q1 400,796 $729,846 -$97,971 $1.82 12
2022 Q4 440,750 $1,011,250 +$306,049 $2.29 18
2022 Q3 298,959 $406,000 +$156,569 $1.36 7
2022 Q2 183,385 $475,000 +$120,000 $2.59 6
2022 Q1 146,485 $352,000 -$5,019,402 $2.39 7
2021 Q4 1,538,439 $5,473,200 +$3,457,200 $3.56 11